Type 2 Diabetes Clinical Trials near Chicago, IL
20 studies for Type 2 Diabetes are recruiting at 28 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Type 2 Diabetes trials in the US or all trials near Chicago.
Recruiting now
Type 2 Diabetes studies enrolling near Chicago
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
NCT07595549
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Cedar Crosse Research Center (Chicago, IL); Northwestern University (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Cedar Crosse Research Center (Chicago, IL); Accellacare of Duly (Oak Lawn, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418
- Interventional
- Ages 55 years and older
- Sex: All
- Accepts healthy volunteers
Nearest sites: Northwestern University (Chicago, IL); Northshore University Health System (Glenview, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Enhancing Diabetes Care: Exposome &Amp; Sensors
NCT06989008
- Observational
- Ages 18 to 65 years
- Sex: All
Nearest sites: University of Illinois - Chicago (Chicago, IL); University of Illinois College of Nursing (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
NCT05208164
- Interventional
- Ages 21 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Illinois at Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
NCT06739122
- Phase 3
- Ages 10 to 17 years
- Sex: All
Nearest site: University of Illinois at Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Achieving Routine Intervention and Screening for Emotional Health
NCT06887049
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
NCT07024823
- Phase 1
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Research Site (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
NCT07271186
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Research by Design, LLC - Internal Medicine (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT07296484
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Chicago Clinical Research Institute (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
NCT07340320
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: AES - DRS - Synexus Clinical Research US, Inc. - Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
NCT07415954
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Cedar-Crosse Research Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT07521475
- Interventional
- Ages 18 to 75 years
- Sex: All
Nearest site: Northwestern University (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NCT07579702
- Interventional
- Ages 14 to 75 years
- Sex: All
Nearest site: Northwestern University (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
NCT07650682
- Observational
- Ages 18 to 65 years
- Sex: All
Nearest site: Illinois Institute of Technology (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- RCT Glargine vs NPH for Treatment of DM in Pregnancy
NCT06619301
- Phase 3
- Ages 18 years and older
- Sex: Female
Nearest site: Loyola University Medical Center (Maywood, IL)
- Distance to nearest recruiting site
- ~10 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: NorthShore University Health System (Skokie, IL)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
NCT07684144
- Phase 3
- Ages 18 to 99 years
- Sex: All
Nearest site: Endeavor Health (Skokie, IL)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
NCT07817251
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Endeavor Health (Skokie, IL)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335
- Phase 3
- Ages 45 years and older
- Sex: All
Nearest sites: Chicago Medical Research LLC (Hazel Crest, IL); Elevate Clinical Research (Gurnee, IL)
- Distance to nearest recruiting site
- ~19 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Type 2 Diabetes clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.